LB-006 - APPLICATION OF PHARMACOKINETIC MODELING & SIMULATION IN DEVELOPMENT OF A LONG-ACTING ANTIBODY (EVUSHELD) COMBINATION FOR THE POTENTIAL PREVENTION AND TREATMENT OF COVID-19.

V. Pilla Reddy¹, O. Stepanov², A. Gebre³, R. Kubiak³, K. Zhudenkov⁴, C. Chen⁵, I. Pouliquen¹, R. Arends³; ¹AstraZeneca, Cambridge, United Kingdom, ²M&S Decisions, Moscow, Russia, ³AstraZeneca, Gaithersburg, MD, USA, ⁴MS&D, Mascow, Russia, ⁵AstraZeneca, South San Francisco, CA, USA.